Cloe® Screen is a cost-effective, high quality in vitro ADME screening service that delivers critical information on absorption (including Caco-2 permeability and PAMPA), distribution (including plasma protein binding), metabolism (including cytochrome P450 inhibition), excretion, toxicity (hERG using patch clamp techniques) and chemical properties for Pharmaceutical and Biotechnology companies.

A collection of bespoke ADME and pharmacokinetic assays designed to meet the requirements of later stage development projects.

Cloe® Predict is a collection of predictive technologies designed to improve efficiency in the Drug Discovery Process. These include the Cyprotex Discovery Bus, Cloe® PK and Cloe® Human Intestinal Absorption Model.